The mortality rate of bladder malignant neoplasms in Canada is forecast to decline slightly from 2024 to 2028. The standardized rate is expected to decrease from 5.5 deaths per hundred thousand in 2024 to 5.3 in 2028. Compared to the rate in 2023, this demonstrates a consistent, albeit slight, downward trend yearly. The year-on-year variation is relatively subtle, reflective of improvements in treatment and early detection.
Future trends to watch for include advancements in personalized medicine and targeted therapies, which may further decrease mortality rates. Improvements in healthcare accessibility and cancer awareness programs are also critical factors that can influence these rates.
